摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-(2-Hydroxyethyl)hypoxanthin | 22247-81-0

中文名称
——
中文别名
——
英文名称
9-(2-Hydroxyethyl)hypoxanthin
英文别名
9-(2-Hydroxyethyl)-1H-purin-6(9H)-one;9-(2-hydroxyethyl)-1H-purin-6-one
9-(2-Hydroxyethyl)hypoxanthin化学式
CAS
22247-81-0
化学式
C7H8N4O2
mdl
——
分子量
180.166
InChiKey
ABRQSAMTUHCYEW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    79.5
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Method of imparting immunomodulating and antiviral activity
    申请人:Newport Pharmaceuticals International, Inc.
    公开号:US04221794A1
    公开(公告)日:1980-09-09
    Compounds of the formula ##STR1## where X is OH, NH.sub.2, SH, OR or SR (where R is alkyl of 1 to 4 carbon atoms or benzyl), R.sup.1 is H or alkyl of 1 to 8 carbon atoms, R.sup.2 is H or methyl, Y is the salt of an amine of the formula ##STR2## where R.sup.3 and R.sup.4 are lower alkyl, e.g., 1 to 4 carbon atoms and n is an integer of 2 to 4 with p-acetamidobenzoic acid and where z is a number from 0 to 10 are useful as immunomodulators, as antiviral agents and in specific cases have anti-leukemic activity. The compounds and compositions where z is 1 to 10 are novel per se. When R.sup.2 is H the presence of Y enhances the immunoregulatory activity and the antiviral activity. If X is the NH.sub.2 there is immunoinhibitory activity but no immunostimulatory (immunopotentiatory) activity.
    式为##STR1##的化合物,其中X为OH、NH.sub.2、SH、OR或SR(其中R为1至4个碳原子的烷基或苄基),R.sup.1为H或1至8个碳原子的烷基,R.sup.2为H或甲基,Y为式为##STR2##的胺盐,其中R.sup.3和R.sup.4为较低的烷基,例如1至4个碳原子,n为2至4的整数,与对乙酰氨基苯甲酸反应,其中z是从0到10的数字,可用作免疫调节剂、抗病毒剂,在特定情况下具有抗白血病活性。当z为1至10时,该化合物和组合物是新颖的。当R.sup.2为H时,Y的存在增强了免疫调节活性和抗病毒活性。如果X为NH.sub.2,则具有免疫抑制活性,但没有免疫刺激(免疫增强)活性。
  • 9-(Hydroxy alkyl)purines
    申请人:Newport Pharmaceuticals International, Inc.
    公开号:US04221910A1
    公开(公告)日:1980-09-09
    There are prepared compounds of the formula ##STR1## where X is OH, R.sup.2 is CH.sub.3 and R.sup.1 is alkyl of 1 to 8 carbon atoms. The compounds are immunopotentiators, have antiviral activity and anti-leukemic activity.
    有一些化合物的配方已经准备好了,该配方为:##STR1## 其中X为OH,R.sup.2为CH.sub.3,R.sup.1为1至8个碳原子的烷基。这些化合物是免疫增强剂,具有抗病毒活性和抗白血病活性。
  • P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
    申请人:Sloan-Kettering Institute for Cancer Research
    公开号:US04221909A1
    公开(公告)日:1980-09-09
    Compounds of the formula ##STR1## where X is OH, NH.sub.2, SH, OR or SR (where R is alkyl of 1 to 4 carbon atoms or benzyl), R.sup.1 is H or alkyl of 1 to 8 carbon atoms, R.sup.2 is H or methyl, Y is the salt of an amine of the formula ##STR2## where R.sup.3 and R.sup.4 are lower alkyl, e.g., 1 to 4 carbon atoms and n is an integer of 2 to 4 with p-acetamidobenzoic acid and where z is a number from 0 to 10 are useful as immunomodulators, as antiviral agents and in specific cases have anti-leukemic activity. The compounds and compositions where z is 1 to 10 are novel per se. When R.sup.2 is H the presence of Y enhances the immunoregulatory activity and the antiviral activity. If X is the NH.sub.2 there is immunoinhibitory activity but no immunostimulatory (immunopotentiatory) activity.
    式为##STR1##的化合物,其中X为OH、NH.sub.2、SH、OR或SR(其中R为1至4个碳原子的烷基或苄基),R.sup.1为H或1至8个碳原子的烷基,R.sup.2为H或甲基,Y为式为##STR2##的胺盐,其中R.sup.3和R.sup.4为较低的烷基,例如1至4个碳原子,n是2至4的整数,与对乙酰氨基苯甲酸结合,其中z为0至10的数字,可用作免疫调节剂、抗病毒剂,并在特定情况下具有抗白血病活性。其中z为1至10的化合物和组合物本身是新颖的。当R.sup.2为H时,Y的存在增强了免疫调节活性和抗病毒活性。如果X为NH.sub.2,则具有免疫抑制活性但没有免疫刺激(免疫增强)活性。
  • Purine compounds endowed with immunomodulating activity
    申请人:CO PHARMA CORPORATION S.r.l.
    公开号:EP0077460A2
    公开(公告)日:1983-04-27
    The invention relates to a series of purine derivatives of formula (I) wherein R is hydrogen or NH2, n is an integer from 1 to 6, R1 is one of the following chains: wherein R2 is the residue of an aminoacid, R3 is hydrogen or the residue of an oligopeptide and R4 is OH or the residue of an oligopeptide.
    本发明涉及一系列式(I)的嘌呤生物,其中 R 是氢或 NH2,n 是 1 至 6 的整数,R1 是下列链之一:其中 R2 是氨基酸残基,R3 是氢或低聚肽残基,R4 是 OH 或低聚肽残基。
  • ——
    作者:
    DOI:——
    日期:——
查看更多